Drug Discovery World

SEPTEMBER 14, 2023

Europe has one of the highest rates of bladder cancer in the world 1 , with more than 203,000 patients diagnosed in 2020 alone 2. Erdafitinib for the treatment of metastatic bladder cancer. UC is the most common form 3 , and up to 20% of patients with metastatic UC (mUC) have FGFR alterations 4. J Clin Med. 2022;11(15): 4483.

Treatment 130

Treatment Clinical Pharmacology FDA Approval Therapies 130

Drug Discovery World

SEPTEMBER 21, 2022

Otsuka Pharmaceutical’s Lupkynis (voclosporin) is the first oral treatment to be approved in Europe for the treatment of active lupus nephritis (LN) in adult patients. The combination treatment for this indication was approved by the US Food and Drug Administration in 2021 and gained a positive opinion from the CHMP earlier this year.

Treatment 130

Treatment Licensing Licensing Pharmaceuticals 130

Drug Discovery World

FEBRUARY 9, 2023

Launched in 2020, the Oxford-based business hopes the designation will “open regulatory discussions, supplement funding, increase the viability of drug development and enable quick access to market a treatment.” SynaptixBio CEO and co-founder Dr Dan Williams said the designation was a “monumental step forward” in its bid to treat the disease. “To

Treatment 130

Treatment Disease Clinical Trials FDA 130

Drug Discovery World

SEPTEMBER 4, 2024

The drug was approved by the FDA for Expanded Access, allowing trial participants to continue CS1 treatment when no comparable or satisfactory alternative therapy options are available. The EU OMPD complements the orphan drug designation (ODD) granted by the US FDA in 2020, enhancing the protection and value of CS1 in these major markets.

Drugs 265

Drugs FDA Marketing Treatment 265

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

Kendal Chidwick NDARC’s Kendal Chidwick discusses the findings from a recently published study that examined how patterns of opioid agonist treatment medicines have changed over the past decade. Other changes around this time aimed at improving treatment accessibility included increased use of take-home doses and telehealth appointments.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Drug Discovery World

OCTOBER 7, 2022

This approval provides a valuable treatment option for children and adolescents suffering with ADHD and sleep onset insomnia, adding further breadth to Colonis’ growing paediatric portfolio while supporting Clinigen Group’s mission to deliver the right medicine to the right patient at the right time.”. 2020 Aug;33(4):533-539.

Treatment 130

Treatment Drugs 130

Drug Target Review

JUNE 8, 2023

An important research area at AbbVie involves blood cancers, where our ultimate goal is to transform standards of care across these diseases and advance a dynamic cancer research and treatment pipeline. 2 However, treatment options were still limited and often came with severe side effects.

Treatment 105

Treatment Organic Chemistry Research Disease 105

Drugs.com

JULY 6, 2023

Centers for Disease Control and Prevention estimates that there were nearly 68,000 new cases of acute hepatitis C in 2020 and over 107,000 newly reported cases of chronic hepatitis C? THURSDAY, July 6, 2023 -- Did you know the U.S. To help you.

Treatment 119

Treatment Disease 119

Common Sense for Drug Policy Blog

NOVEMBER 29, 2023

Receipt of Opioid Use Disorder Treatments Prior to Fatal Overdoses and Comparison to No Treatment "The findings revealed that exposures to MOUD, even if not continued throughout the six-month exposure period was associated with reduced risk of a fatal poisoning compared to non-MOUD forms of treatment and no treatment exposure.

Treatment 52

Treatment Drugs 52

Eye on FDA

JANUARY 6, 2021

During 2020, FDA was able to approve 53 – not surpassing the 2018 all time record of 59, but certainly an admirable second place. Notably, the 2020 NME approvals included 22 related to oncology, with 2 new GIST treatments, 3 in breast cancer and 2 approvals in prostate cancer. That, however, was not really the case.

FDA 82

FDA Vaccine Clinical Trials Treatment 82

Eye on FDA

FEBRUARY 10, 2021

Looking now to a review of enforcement by the Office of Prescription Drug Promotion (OPDP) in 2020, we see a different picture. The collection of letters issued by OPDP during 2020 can be found here. We instead see the same pace as we have the past several years – that is anemic levels of enforcement.

Biosimilars 77

Biosimilars FDA Production Treatment 77

SCIENMAG: Medicine & Health

JULY 5, 2023

But a study published by The BMJ today finds that less than half of approved first indications for new drugs in the US and Europe between 2011 and 2020 add substantial therapeutic value over existing treatments […]

Treatment 67

Treatment Drugs Disease 67

National Drug & Alcohol Research Centre Blog

NOVEMBER 12, 2023

Professor Shane Darke NDARC's Professor Shane Darke discusses the findings of a new study published in Addiction journal, which found that 610 people died from heroin overdose between 2020-22. In order to examine the situation regarding fatal heroin overdose in Australia in the early 2020s, we examined all cases over the period 2020 to 2022.

Treatment 52

Treatment Drugs 52

The Pharma Data

NOVEMBER 18, 2020

The 2020 updated HIV drug resistance strategy – which is to be released before the end of the year – considers lessons learned in the field over the last decade and anticipates the ongoing scale-up of antiretroviral therapy and HIV pre-exposure. Map of countries implementing national HIV drug resistance surveys, 2004–2020. .

Laboratories 52

Laboratories Virus Government Therapies 52

The Pharma Data

NOVEMBER 9, 2020

An experimental Alzheimer’s disease treatment should not be approved by the U.S. “If we approve something when the data is not strong, we have a risk of delaying good treatments and effective treatments for more than a couple of years, for many years,” Perlmutter said. © 2020 HealthDay. .

Pharmaceutical Companies 52

Pharmaceutical Companies Treatment FDA Disease 52

Drug Discovery World

AUGUST 14, 2024

This marks the first cell therapy to enter Phase lI trials in both the US and China for the treatment of relapsed/metastatic EBV-positive nasopharyngeal carcinoma. All patients are late-stage cancer patients failing standard treatment including checkpoint inhibitors.

Therapies 130

Therapies Trials Clinical Trials FDA 130

Drug Discovery World

JULY 2, 2024

It is recommended as a monotherapy to treat adult patients with unresectable or metastatic urothelial carcinoma, harbouring susceptible FGFR3 genetic alterations who have previously received at least one line of therapy containing a PD-1 or PD-L1 inhibitor in the unresectable or metastatic treatment setting. months vs 7.8 months vs 2.7

Therapies 148

Therapies Treatment Production Disease 148

The Pharma Data

JANUARY 20, 2021

a medical device company focused on the development and commercialization of treatments focused on the development and commercialization of treatments for knee pain caused by osteoarthritis (OA), today announced its company highlights for 2020 which have exceeded revenue targets. . DOYLESTOWN, Pa. ,

Production 52

Production Compliance Treatment Licensing 52

Eye on FDA

MARCH 5, 2023

By contrast, already in 2023 there have been eight AdComm meetings scheduled by FDA for the purpose of considering a new medical treatment, three of which have occurred and all resulting in votes in favor of the sponsor, so perhaps 2023 is heading to less negative territory. There are a lot of variables that factor in.

FDA 72

FDA Vaccine Drugs Therapies 72

The Pharma Data

MAY 14, 2021

Product Name: Home – Beat Kidney Disease – 2020 – Beat Kidney Disease. Home – Beat Kidney Disease – 2020 – Beat Kidney Disease is backed with a 60 Day No Questions Asked Money Back Guarantee. Always consult your physician before beginning any treatment, diet, or exercise program.

Disease 52

Disease Production Licensing Licensing 52

The Pharma Data

NOVEMBER 3, 2020

4, 2020 /PRNewswire/ — Q3 2020 highlights. Updated financial outlook 2020. 2020 Jul-Sep. 2020 Jan-Sep. 2019-2020 Jul-Sep ?. . Updated financial outlook 2020.

Therapies 52

Therapies Pharmaceuticals Production Marketing 52

Drug Discovery World

NOVEMBER 16, 2023

Casgevy (exagamglogene autotemcel, or exa-cel) is the first medicine to be licensed that uses gene editing tool CRISPR, for which its inventors were awarded the Nobel Prize in 2020. To date, a bone marrow transplant – which must come from a closely matched donor and carries a risk of rejection – has been the only permanent treatment option.

Therapies 278

Therapies Clinical Trials Trials Treatment 278

The Pharma Data

JANUARY 12, 2021

(NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases, today reported preliminary unaudited fourth quarter 2020 revenue. million to $48.9 About Inari Medical, Inc. Inari Medical, Inc.

FDA 52

FDA Production Treatment Disease 52

The Pharma Data

NOVEMBER 30, 2020

The UK-based RECOVERY trial, which is evaluating multiple treatments for COVID-19, will add the inexpensive anti-inflammatory drug colchicine to the list of therapies being tested in hospitalized patients.

Treatment 52

Treatment Trials Hospitals Therapies 52

The Pharma Data

NOVEMBER 8, 2020

Verona Pharma is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of respiratory diseases with significant unmet medical needs. LONDON and RALEIGH, N.C.,

Therapies 52

Therapies Treatment Disease Hospitals 52

The Pharma Data

OCTOBER 21, 2020

22, 2020 (GLOBE NEWSWIRE) — Athenex, Inc. is a global clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of next generation drugs for the treatment of cancer. BUFFALO, N.Y., Founded in 2003, Athenex, Inc. For more information, please visit www.athenex.com.

Engineering 52

Engineering Therapies International Treatment 52

The Pharma Data

DECEMBER 30, 2020

The year 2020 will certainly go down in history as the year of COVID-19. Gilead Sciences Makes Multiple Bets : When Gilead Sciences wasn’t working on remdesivir in COVID-19, the company seemed to be constantly flexing its M&A muscle over the course of 2020. It began in May with the $4.9

Science 52

Science Pharmaceuticals Disease FDA Approval 52

The Pharma Data

OCTOBER 20, 2020

21, 2020 /PRNewswire/ — Ionis Pharmaceuticals, Inc. Eastern Time to discuss its third quarter 2020 financial results and report on pipeline and business progress. Webcast scheduled for Wednesday, November 4 at 11:30 a.m. Eastern Time. . CARLSBAD, Calif. , Interested parties may access the webcast at www.ionispharma.com.

RNA 52

RNA Pharmaceuticals Disease Treatment 52

The Pharma Data

DECEMBER 29, 2020

Primary Aldosteronism Testing Rare in Treatment-Resistant HTN. 29, 2020 — Patients with apparent treatment-resistant hypertension are rarely tested for primary aldosteronism, according to a study published online Dec. Veterans Health Administration with apparent treatment-resistant hypertension from 2000 to 2017.

Treatment 52

Treatment International Therapies Research 52

Drug Channels

NOVEMBER 2, 2020

Rare Disease Innovation and Partnering Summit 2020. December 1-4, 2020 | Virtual Event www.raredisease-summit.com. Co-founder and Executive Director, CASTLEMAN DISEASE COLLABORATIVE NETWORK Technology Spotlight - Using AI to Speed Discovery and New Treatments. Copyright © 2006-2020 Pembroke Consulting, Inc.

Disease 52

Disease FDA Pharmaceuticals Hospitals 52

The Pharma Data

NOVEMBER 25, 2020

AHA: Ablation Better Than Meds for Initial A-Fib Treatment. 25, 2020 — Cryoballoon ablation is superior to drug therapy as an initial treatment for the prevention of atrial arrhythmia recurrence in patients with paroxysmal atrial fibrillation , according to a study published online Nov. © 2020 HealthDay. Wazni, M.D.,

Treatment 52

Treatment Therapies Disease Drugs 52

The Pharma Data

NOVEMBER 18, 2020

19, 2020 /PRNewswire/ — Summary. Financial overview July 1 – September 30, 2020. Significant events during the period July 1 – September 30, 2020. 2020 Jul – Sep. 2020 Jan – Sep. STOCKHOLM , Nov. M (0.0).

FDA 40

FDA Pharmaceutical Companies Marketing Treatment 40

The Pharma Data

NOVEMBER 10, 2020

Antibody Treatment Approved for Emergency Use Against Early COVID-19. 10, 2020 — Eli Lilly’s experimental antibody treatment for COVID-19 was given emergency approval by the U.S. Instead, the treatment should be given as soon as possible after a positive test and within 10 days of developing symptoms.

Treatment 52

Treatment Government Hospitals FDA 52

The Pharma Data

DECEMBER 28, 2020

Triple Treatment Combo Beneficial in BRAF-Mutant CRC. 28, 2020 — Irinotecan and cetuximab combined with vemurafenib improve progression-free survival in BRAF V600E -mutated colorectal cancer (CRC), according to a study published online Dec. © 2020 HealthDay. Posted: December 2020. Professional. MONDAY, Dec.

Treatment 52

Treatment RNA DNA Disease 52

The Pharma Data

SEPTEMBER 24, 2020

NYSE:PFE) declared a 38-cent fourth-quarter 2020 dividend on the company’s common stock, payable December 1, 2020, to holders of the Common Stock of record at the close of business on November 6, 2020. The fourth-quarter 2020 cash dividend will be the 328 th consecutive quarterly dividend paid by Pfizer. Pfizer Inc.:

Government 40

Government Vaccine Science Therapies 40

Drugs.com

MAY 15, 2024

cancer death rates are continuing to drop, falling by 33% between 1991 and 2020.However, However, not all Americans are reaping the benefits from advances in cancer prevention, early detection and treatment, a new report from. WEDNESDAY, May 15, 2024 -- U.S.

Treatment 98

Treatment 98

The Pharma Data

DECEMBER 17, 2020

18, 2020 /PRNewswire/ — Camurus AB (NASDAQ STO: CAMX) announced today that the Swiss agency for therapeutic products, Swissmedic, has approved weekly and monthly Buvidal ® prolonged release buprenorphine for the treatment of opioid dependence in adults and adolescents from 16 years of age. LUND, Sweden , Dec. About Buvidal.

Treatment 52

Treatment Clinical Trials International Pharmaceutical Companies 52